|Articles|May 2, 2004
- Pharmaceutical Technology-05-02-2004
- Volume 28
- Issue 5
FDA Eyes Manufacturing Innovation to Boost Drug Development
Author(s)Jill Wechsler
New technologies, along with changes in FDA oversight, may provide a critical path to make more new drugs available more quickly to patients.
Advertisement
Articles in this issue
almost 22 years ago
Characterization of the Performance of Bin Blenders Part 1 of 3: Methodologyalmost 22 years ago
In The Spotlight-May 2004almost 22 years ago
Prepare for Bar Codingalmost 22 years ago
aaiPharma Situation Underscores The Need for Due Diligencealmost 22 years ago
Excipient Functionalityalmost 22 years ago
Characterization of the Performance of Bin Blenders Part 1 of 3: Methodologyalmost 22 years ago
May 2004Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Women in STEM: Early Phase Drug Development
2
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
3
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
4
PharmTech Weekly Roundup - February 6, 2026
5